Dr. Joseph Charles Shanahan, MD

Dr. Shanahan practices at Shanahan Rheumatology and Immunotherapy in Raleigh, North Carolina.

Dr. Shanahan's NPI, 1043394901, was assigned on October 25, 2006. Dr. Shanahan graduated from Rutgers New Jersey Medical School in 1997. Dr. Shanahan holds North Carolina license 98-01767.

Dr. Shanahan's primary practice is Shanahan Rheumatology and Immunotherapy, at 10208 Cerny St, Raleigh, NC 27617 in Wake County. The practice phone is (919) 949-2228.

Dr. Shanahan's primary practice is Shanahan Rheumatology and Immunotherapy in Raleigh, North Carolina. Dr. Shanahan is also affiliated with UNC Health Rex. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Shanahan to 1 more hospital, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shanahan practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Shanahan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Shanahan is licensed in North Carolina.

CMS data shows 243,018 Medicare services from Dr. Shanahan across 19 procedure codes in 2024, for 581 Medicare patients. Medicare paid $1,862,108 for them. Every service was in an office.

CMS counts 581 Medicare patients who saw Dr. Shanahan in 2024. The largest group is 65 to 74, with 281 patients. 75% of them have arthritis, and 73% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shanahan's median patient age at 62, with 69% women.

In 2024, Dr. Shanahan wrote 4,583 Medicare Part D claims for 635 patients. 78% of them were for generic drugs. CMS names the drug for 4,174 of them, across 80 drugs with 11 or more claims each, at $5,491,044 in total drug cost. In 2023, CMS named 3,869 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Shanahan for performance year 2024, reported individually. Dr. Shanahan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Shanahan to 3 clinical trials. Conditions studied include Axial Spondyloarthritis, Ankylosis and Arthritis, Rheumatoid. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Shanahan that name 3 trials.

CMS Open Payments shows 1,441 general payments to Dr. Shanahan from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Celgene Corporation paid the most, $356,508. It also lists 3 research payments totaling $6,919 from 2016 to 2018, naming 3 clinical trials.

Dr. Shanahan graduated from Rutgers New Jersey Medical School in 1997.